Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity Diana Hernández-Flórez, Lara Valor

Rheumatoid Arthritis, a New Focus on Cardiovascular Risk Erardo Meriño-Ibarra, Concepción Delgado-Beltrán

Cardiovascular risk in rheumatoid arthritis. Up to what point? Víctor Martínez Taboada, Loreto Carmona